Chen et al. [82] reported that the epithelial cell transforming sequence 2 (ECT2) oncogene expressed by CTCs in peripheral blood had higher sensitivity than the serum CEA level; it was highly expressed in patients with advanced-stage CRC. Here, CEACAM5 is linked to colorectal carcinoma.